303 related articles for article (PubMed ID: 18725418)
1. A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG.
Tullius MV; Harth G; Maslesa-Galic S; Dillon BJ; Horwitz MA
Infect Immun; 2008 Nov; 76(11):5200-14. PubMed ID: 18725418
[TBL] [Abstract][Full Text] [Related]
2. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
3.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
4. A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG.
Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
Vaccine; 2006 Mar; 24(10):1593-600. PubMed ID: 16257099
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Mycobacterium bovis BCG.
Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
[TBL] [Abstract][Full Text] [Related]
8. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
[TBL] [Abstract][Full Text] [Related]
9. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.
Bao L; Chen W; Zhang H; Wang X
Infect Immun; 2003 Apr; 71(4):1656-61. PubMed ID: 12654778
[TBL] [Abstract][Full Text] [Related]
10. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.
Horwitz MA; Harth G; Dillon BJ; Maslesa-Galic' S
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13853-8. PubMed ID: 11095745
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
12. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of BCG vaccine: a double-edged sword.
Singh VK; Srivastava R; Srivastava BS
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
15. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
[TBL] [Abstract][Full Text] [Related]
16. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
18. Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
Williams A; Goonetilleke NP; McShane H; Clark SO; Hatch G; Gilbert SC; Hill AV
Infect Immun; 2005 Jun; 73(6):3814-6. PubMed ID: 15908420
[TBL] [Abstract][Full Text] [Related]
19. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
[TBL] [Abstract][Full Text] [Related]
20. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
